Close
ACHEMA MIDDLE EAST 2026
DDF Summit 2025

Tag: America

Browse our exclusive articles!

Dr Reddy’s drops as US agency charges firm for packaging lapses

The US CPSC, which is tasked with protecting children and families from risks of injuries or death associated with consumer products, had taken issue...

Biogen tanks as opicinumab misses Phase II endpoints in MS trial

Biogen reported top-line results from the Phase 2 SYNERGY study evaluating opicinumab (anti-LINGO-1), an investigational, fully human monoclonal antibody being developed as a potential...

Pharma Giant Eli Lilly Wants to Launch 20 New Drugs by 2023

Indianapolis-based pharmaceutical giant Eli Lilly LLY -0.64% laid out an ambitious R&D agenda for launching up to 20 new drugs by 2023 during an...

AbbVies Showcased at Digestive Disease Week with New HUMIRA ,Real-World Research and Promising Anti-IL-23 Antibody Late-Breaking Data

Data presentations further evaluate HUMIRA® (adalimumab) for the treatment of inflammatory bowel diseases including moderate to severe Crohn's disease in adult and pediatric...

Merck & Co Inc Final overall survival (OS) dataData from KEYNOTE-006 and KEYNOTE-001 in Advanced Melanoma To Be Presented at 2016 ASCO Annual Meeting

Final Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1 Monotherapy to Demonstrate Overall Survival Compared to Ipilimumab, Shows...

Popular

Building the Right Team and Resource Model to Support Quality System and Validation Activities

Since life science quality and validation projects can vary...

Merck and Blackstone Enter R&D Funding Agreement for sac-TMT

Merck, recognized as MSD outside the U.S. and Canada,...

FDA Approves J&J’s DARZALEX FASPRO for HR-SMM in Adults

Johnson & Johnson said the U.S. Food and Drug...

FDA Approves UCB’s KYGEVVI for Thymidine Kinase 2 Deficiency

UCB, a leading global biopharmaceutical company, has announced that...

Subscribe

spot_imgspot_img